Anova Cancer Care Brings Future of Lung Cancer Treatment to Denver
Armada Medical MarketingDan Snyders, 303-623-1190 x230
, one of the most advanced cancer treatment centers in the nation, is pioneering the use of CyberKnife radiosurgery treatment for lung cancer. The center offers new hope to patients with early stage lung cancer by providing an alternative to less effective treatments and invasive surgery.
“There is another option for these patients,” said Anova Cancer Care Medical Director Gregg Dickerson, M.D. “Patients don’t have to choose longer-term, less effective treatments with more complications. CyberKnife allows patients who don’t want surgery or have been told they weren’t candidates for surgery to successfully treat their cancer without an operation, drugs or a long-term recovery period.”
Candidates for CyberKnife outpatient lung cancer treatment include patients with inoperable early stage I non-small cell lung cancer (NSCLC), and patients with operable NSCLC but who want a minimally invasive alternative to traditional surgery.
Anova Cancer Care is one of only a handful of centers in the U.S. to offer CyberKnife radiosurgery treatment and has the most experienced CyberKnife team in the region. Unlike other treatment systems, CyberKnife real-time tracking technology automatically tracks and corrects for tumor location with patient movement during the procedure, enabling more accurate treatment and better preservation of healthy tissue.
The American Cancer Society estimates that more than 200,000 people in the U.S. will be diagnosed with lung cancer this year. During Lung Cancer Awareness Month this November, Anova Cancer Care aims to bring attention to this disease and inform newly diagnosed patients with Stage I lung cancer about the CyberKnife.
Despite its name, CyberKnife does not involve any incisions. Instead, the technology identifies the precise size and location of the tumor and then delivers concentrated doses of radiation directly to it, avoiding damage to the surrounding tissues. The treatment can be done in about five sessions without cutting or anesthesia, resulting in minimal disruption to the patient’s work schedule and lifestyle. In contrast, patients who opt for a lobectomy, where part of the lung is removed, can expect a six- to eight-week recovery period before they are allowed to resume their normal routine.
As with most cancers, early detection is the key to a better survival rate. Catching NSCLC at Stage I means the tumor is localized and has not spread to any lymph nodes or distant organs, making it the stage where long-term survival chances are better.
However, most lung cancers are not caught until they are in an advanced stage, killing more people every year than breast, prostate, colon, and pancreatic cancers combined. The American Cancer Society estimates 160,000 people will die from lung cancer in the U.S. this year.
Lung Cancer Awareness Month started as Lung Cancer Awareness Day back in 1995 in the U.S. Since then it has grown into an international movement with observances, events and fundraisers to promote awareness for this often ignored disease. Anova Cancer Care is proud to support lung cancer awareness and early detection in support of patients and their families who are battling the disease.
For more information about Anova Cancer Care, visit or call 303-396-1419. Anova Cancer Care is on Facebook at and on Twitter at .